Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Neupro TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: rotigotine
Brand name
(ARTG)
: NEUPRO rotigotine 8 mg/24hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 8 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 2 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 2 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 8 mg/24hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 8 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 2 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 2 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 4 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 4 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 2 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 2 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 6 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 6 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 6 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 6 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 4 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 4 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 4 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 4 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 6 mg/24 hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 6 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: NEUPRO rotigotine 8 mg/24hr transdermal patch sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Parkinson's disease: Neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic Parkinson's disease from early stage to advanced disease. Restless Legs Syndrome: Neupro is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Drug delivery system, transdermal
- Transdermal
- A thin, matrix-type patch that is square-shaped with rounded corners. The outside of the backing layer is tan coloured and imprinted with Neupro 8 mg/24 hr.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 100 patches pack
- 28 patches pack
- 7 patches pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rotigotine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.